Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | October 09, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7SQ9 | Q99J21 | Cryo-EM structure of mouse temsirolimus/PI(3,5)P2-bound TRPML1 channel at 2.11 Angstrom resolution | |
| 7SQF | Q9H813 | Structure of the human proton-activated chloride channel ASOR in activated conformation | |
| 7SQG | Q9H813 | Structure of the human proton-activated chloride channel ASOR in resting conformation | |
| 7SQH | Q9H813 | Structure of the human proton-activated chloride channel ASOR in desensitized conformation | |
| 7SR9 | P00734 | Human alpha-thrombin with 180- and 220- loops replaced with homologous loops from protein C | |
| 7SRQ | P41595 | 5-HT2B receptor bound to LSD obtained by cryo-electron microscopy (cryoEM) | |
| 7SRS | P49407 | 5-HT2B receptor bound to LSD in complex with beta-arrestin1 obtained by cryo-electron microscopy (cryoEM) | |
| 7SRS | 7SRS | 5-HT2B receptor bound to LSD in complex with beta-arrestin1 obtained by cryo-electron microscopy (cryoEM) | |
| 7SSQ | Q05320 | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075231 | |
| 7SSQ | 7SSQ | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075231 | |
| 7SSQ | Q05320 | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075231 | |
| 7SSQ | 7SSQ | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075231 | |
| 7SSR | Q05320 | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075093 | |
| 7SSR | 7SSR | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075093 | |
| 7SSR | Q05320 | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075093 | |
| 7SSR | 7SSR | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075093 | |
| 7STZ | 7STZ | Crystal Structure of Human E-cadherin EC1-5 bound by mouse monoclonal antibody Fab mAb-1_19A11 | |
| 7STZ | P12830 | Crystal Structure of Human E-cadherin EC1-5 bound by mouse monoclonal antibody Fab mAb-1_19A11 | |
| 7STZ | 7STZ | Crystal Structure of Human E-cadherin EC1-5 bound by mouse monoclonal antibody Fab mAb-1_19A11 | |
| 7STZ | P12830 | Crystal Structure of Human E-cadherin EC1-5 bound by mouse monoclonal antibody Fab mAb-1_19A11 | |
| 7SU0 | P16410 | Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.105 in complex with CTLA-4 | |
| 7SU0 | 7SU0 | Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.105 in complex with CTLA-4 | |
| 7SU1 | P16410 | Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4 | |
| 7SU1 | 7SU1 | Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4 | |
| 7SWD | A0A089X075 | Structure of EBOV GP lacking the mucin-like domain with 1C11 scFv and 1C3 Fab bound | |
| 7SWD | A0A7S6GAH2 | Structure of EBOV GP lacking the mucin-like domain with 1C11 scFv and 1C3 Fab bound | |
| 7SWD | 7SWD | Structure of EBOV GP lacking the mucin-like domain with 1C11 scFv and 1C3 Fab bound | |
| 7SWW | P0DTC2 | SARS-CoV-2 Spike NTD in complex with neutralizing Fab SARS2-57 (local refinement) | |
| 7SWW | 7SWW | SARS-CoV-2 Spike NTD in complex with neutralizing Fab SARS2-57 (local refinement) | |
| 7SWX | P0DTC2 | SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-57 (three down conformation) | |
| 7SWX | 7SWX | SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-57 (three down conformation) | |
| 7SX3 | Q8IZF0 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 1/2 | |
| 7SX3 | A0A7G8ZY66 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 1/2 | |
| 7SX3 | B1AL88 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 1/2 | |
| 7SX3 | P0DP23 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 1/2 | |
| 7SX3 | 7SX3 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 1/2 | |
| 7SX3 | Q9P2D8 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 1/2 | |
| 7SX3 | 7SX3 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 1/2 | |
| 7SX3 | Q9P2D8 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 1/2 | |
| 7SX3 | Q8N2C7 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 1/2 | |
| 7SX4 | Q8IZF0 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 2/2 | |
| 7SX4 | A0A7G8ZY66 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 2/2 | |
| 7SX4 | B1AL88 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 2/2 | |
| 7SX4 | P0DP23 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 2/2 | |
| 7SX4 | Q9P2D8 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 2/2 | |
| 7SX4 | 7SX4 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 2/2 | |
| 7SX4 | Q9P2D8 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 2/2 | |
| 7SX4 | 7SX4 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 2/2 | |
| 7SX4 | Q8N2C7 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 2/2 | |
| 7SX6 | A0A0M3KKW9 | Crystal structure of broadly neutralizing antibody N49P9.3 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core |
